Need help finding what you are looking for?
Contact Us
PUBLISHER: IMARC | PRODUCT CODE: 1541018
PUBLISHER: IMARC | PRODUCT CODE: 1541018
Neurological Biomarkers Market Report by Type, Application, End Use, and Region 2024-2032
PUBLISHED:
PAGES: 142 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
The global neurological biomarkers market size reached US$ 8.9 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 24.0 Billion by 2032, exhibiting a growth rate (CAGR) of 11.3% during 2024-2032.
Neurological biomarkers are molecules present in the blood or cerebral spinal fluid (CSF) that support the diagnosis of brain disorders and monitor disease progression. The main sources of these biomarkers are genetic mutations, metabolite levels, brain imaging and changes in protein expression or post-translational modifications. As they detect biological responses to experimental drugs and aid in discovering new targets for therapeutic intervention, neurological biomarkers are widely used in clinical practice during drug development. Presently, researchers measure biomarker concentrations to provide non-invasive testing, earlier diagnosis and personalized treatments.
The rising occurrence of neurological disorders, such as stroke, motor neuron disease (MND), Alzheimer's disease (AD), Parkinson's disease (PD) and Huntington's disease (HD), is escalating the need for faster drug development. This represents one of the primary factors impelling the market growth as biomarkers help measure the efficacy of new drugs and therapeutic strategies. The increasing adoption of minimally invasive procedures and personalized medicines are acting as another major growth-inducing factor. Apart from this, as various neurological disorders share standard features, there is an increase in the demand for multiple biomarkers to differentiate specific diseases and their sub-types. Moreover, advancements in mass spectrometry and imaging procedures enable faster evaluation of large numbers of biochemical markers and structural changes in the brain. This, along with the introduction of digital biomarkers and the rising number of clinical trials, is anticipated to propel the growth of the market in the coming years.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global neurological biomarkers market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on type, application and end use.
Breakup by Type:
Genomic Biomarkers
Proteomic Biomarkers
Metabolomic Biomarkers
Imaging Biomarkers
Others
Breakup by Application:
Alzheimer's Disease
Parkinson's Disease
Multiple Sclerosis
Autism Spectrum Disorders
Others
Breakup by End Use:
Hospital Laboratories
Clinical Diagnostic Centers
Research Organizations
Others
Breakup by Region:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Acumen Pharmaceuticals Inc., Athena Diagnostics (Quest Diagnostics), Banyan Biomarkers Inc., Bio-Rad Laboratories Inc., Immunarray Pvt. Ltd., Myriad Rbm Inc. (Myriad Genetics Inc.), Proteome Sciences Plc and Thermo Fisher Scientific Inc.
Key Questions Answered in This Report:
- How has the global neurological biomarkers market performed so far and how will it perform in the coming years?
- What has been the impact of COVID-19 on the global neurological biomarkers market?
- What are the key regional markets?
- What is the breakup of the market based on the type?
- What is the breakup of the market based on the application?
- What is the breakup of the market based on the end use?
- What are the various stages in the value chain of the industry?
- What are the key driving factors and challenges in the industry?
- What is the structure of the global neurological biomarkers market and who are the key players?
- What is the degree of competition in the industry?
Product Code: SR112024A3181
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
5 Global Neurological Biomarkers Market
- 5.1 Market Overview
- 5.2 Market Performance
- 5.3 Impact of COVID-19
- 5.4 Market Forecast
6 Market Breakup by Type
- 6.1 Genomic Biomarkers
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
- 6.2 Proteomic Biomarkers
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
- 6.3 Metabolomic Biomarkers
- 6.3.1 Market Trends
- 6.3.2 Market Forecast
- 6.4 Imaging Biomarkers
- 6.4.1 Market Trends
- 6.4.2 Market Forecast
- 6.5 Others
- 6.5.1 Market Trends
- 6.5.2 Market Forecast
7 Market Breakup by Application
- 7.1 Alzheimer's Disease
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
- 7.2 Parkinson's Disease
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
- 7.3 Multiple Sclerosis
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
- 7.4 Autism Spectrum Disorders
- 7.4.1 Market Trends
- 7.4.2 Market Forecast
- 7.5 Others
- 7.5.1 Market Trends
- 7.5.2 Market Forecast
8 Market Breakup by End Use
- 8.1 Hospital Laboratories
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
- 8.2 Clinical Diagnostic Centers
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
- 8.3 Research Organizations
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
- 8.4 Others
- 8.4.1 Market Trends
- 8.4.2 Market Forecast
9 Market Breakup by Region
- 9.1 North America
- 9.1.1 United States
- 9.1.1.1 Market Trends
- 9.1.1.2 Market Forecast
- 9.1.2 Canada
- 9.1.2.1 Market Trends
- 9.1.2.2 Market Forecast
- 9.1.1 United States
- 9.2 Asia-Pacific
- 9.2.1 China
- 9.2.1.1 Market Trends
- 9.2.1.2 Market Forecast
- 9.2.2 Japan
- 9.2.2.1 Market Trends
- 9.2.2.2 Market Forecast
- 9.2.3 India
- 9.2.3.1 Market Trends
- 9.2.3.2 Market Forecast
- 9.2.4 South Korea
- 9.2.4.1 Market Trends
- 9.2.4.2 Market Forecast
- 9.2.5 Australia
- 9.2.5.1 Market Trends
- 9.2.5.2 Market Forecast
- 9.2.6 Indonesia
- 9.2.6.1 Market Trends
- 9.2.6.2 Market Forecast
- 9.2.7 Others
- 9.2.7.1 Market Trends
- 9.2.7.2 Market Forecast
- 9.2.1 China
- 9.3 Europe
- 9.3.1 Germany
- 9.3.1.1 Market Trends
- 9.3.1.2 Market Forecast
- 9.3.2 France
- 9.3.2.1 Market Trends
- 9.3.2.2 Market Forecast
- 9.3.3 United Kingdom
- 9.3.3.1 Market Trends
- 9.3.3.2 Market Forecast
- 9.3.4 Italy
- 9.3.4.1 Market Trends
- 9.3.4.2 Market Forecast
- 9.3.5 Spain
- 9.3.5.1 Market Trends
- 9.3.5.2 Market Forecast
- 9.3.6 Russia
- 9.3.6.1 Market Trends
- 9.3.6.2 Market Forecast
- 9.3.7 Others
- 9.3.7.1 Market Trends
- 9.3.7.2 Market Forecast
- 9.3.1 Germany
- 9.4 Latin America
- 9.4.1 Brazil
- 9.4.1.1 Market Trends
- 9.4.1.2 Market Forecast
- 9.4.2 Mexico
- 9.4.2.1 Market Trends
- 9.4.2.2 Market Forecast
- 9.4.3 Others
- 9.4.3.1 Market Trends
- 9.4.3.2 Market Forecast
- 9.4.1 Brazil
- 9.5 Middle East and Africa
- 9.5.1 Market Trends
- 9.5.2 Market Breakup by Country
- 9.5.3 Market Forecast
10 SWOT Analysis
- 10.1 Overview
- 10.2 Strengths
- 10.3 Weaknesses
- 10.4 Opportunities
- 10.5 Threats
11 Value Chain Analysis
12 Porters Five Forces Analysis
- 12.1 Overview
- 12.2 Bargaining Power of Buyers
- 12.3 Bargaining Power of Suppliers
- 12.4 Degree of Competition
- 12.5 Threat of New Entrants
- 12.6 Threat of Substitutes
13 Price Analysis
14 Competitive Landscape
- 14.1 Market Structure
- 14.2 Key Players
- 14.3 Profiles of Key Players
- 14.3.1 Abbott Laboratories
- 14.3.1.1 Company Overview
- 14.3.1.2 Product Portfolio
- 14.3.1.3 Financials
- 14.3.1.4 SWOT Analysis
- 14.3.2 Acumen Pharmaceuticals Inc.
- 14.3.2.1 Company Overview
- 14.3.2.2 Product Portfolio
- 14.3.3 Athena Diagnostics (Quest Diagnostics)
- 14.3.3.1 Company Overview
- 14.3.3.2 Product Portfolio
- 14.3.4 Banyan Biomarkers Inc.
- 14.3.4.1 Company Overview
- 14.3.4.2 Product Portfolio
- 14.3.5 Bio-Rad Laboratories Inc.
- 14.3.5.1 Company Overview
- 14.3.5.2 Product Portfolio
- 14.3.5.3 Financials
- 14.3.5.4 SWOT Analysis
- 14.3.6 Immunarray Pvt. Ltd.
- 14.3.6.1 Company Overview
- 14.3.6.2 Product Portfolio
- 14.3.7 Myriad Rbm Inc. (Myriad Genetics Inc.)
- 14.3.7.1 Company Overview
- 14.3.7.2 Product Portfolio
- 14.3.8 Proteome Sciences Plc
- 14.3.8.1 Company Overview
- 14.3.8.2 Product Portfolio
- 14.3.8.3 Financials
- 14.3.8.4 SWOT Analysis
- 14.3.9 Thermo Fisher Scientific Inc.
- 14.3.9.1 Company Overview
- 14.3.9.2 Product Portfolio
- 14.3.9.3 Financials
- 14.3.9.4 SWOT Analysis
- 14.3.1 Abbott Laboratories
Product Code: SR112024A3181
List of Figures
- Figure 1: Global: Neurological Biomarkers Market: Major Drivers and Challenges
- Figure 2: Global: Neurological Biomarkers Market: Sales Value (in Billion US$), 2018-2023
- Figure 3: Global: Neurological Biomarkers Market Forecast: Sales Value (in Billion US$), 2024-2032
- Figure 4: Global: Neurological Biomarkers Market: Breakup by Type (in %), 2023
- Figure 5: Global: Neurological Biomarkers Market: Breakup by Application (in %), 2023
- Figure 6: Global: Neurological Biomarkers Market: Breakup by End Use (in %), 2023
- Figure 7: Global: Neurological Biomarkers Market: Breakup by Region (in %), 2023
- Figure 8: Global: Neurological Biomarkers (Genomic Biomarkers) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 9: Global: Neurological Biomarkers (Genomic Biomarkers) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 10: Global: Neurological Biomarkers (Proteomic Biomarkers) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 11: Global: Neurological Biomarkers (Proteomic Biomarkers) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 12: Global: Neurological Biomarkers (Metabolomic Biomarkers) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 13: Global: Neurological Biomarkers (Metabolomic Biomarkers) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 14: Global: Neurological Biomarkers (Imaging Biomarkers) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 15: Global: Neurological Biomarkers (Imaging Biomarkers) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 16: Global: Neurological Biomarkers (Others) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 17: Global: Neurological Biomarkers (Others) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 18: Global: Neurological Biomarkers (Alzheimer's Disease) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 19: Global: Neurological Biomarkers (Alzheimer's Disease) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 20: Global: Neurological Biomarkers (Parkinson's Disease) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 21: Global: Neurological Biomarkers (Parkinson's Disease) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 22: Global: Neurological Biomarkers (Multiple Sclerosis) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 23: Global: Neurological Biomarkers (Multiple Sclerosis) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 24: Global: Neurological Biomarkers (Autism Spectrum Disorders) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 25: Global: Neurological Biomarkers (Autism Spectrum Disorders) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 26: Global: Neurological Biomarkers (Others) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 27: Global: Neurological Biomarkers (Others) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 28: Global: Neurological Biomarkers (Hospital Laboratories) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 29: Global: Neurological Biomarkers (Hospital Laboratories) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 30: Global: Neurological Biomarkers (Clinical Diagnostic Centers) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 31: Global: Neurological Biomarkers (Clinical Diagnostic Centers) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 32: Global: Neurological Biomarkers (Research Organizations) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 33: Global: Neurological Biomarkers (Research Organizations) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 34: Global: Neurological Biomarkers (Others) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 35: Global: Neurological Biomarkers (Others) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 36: North America: Neurological Biomarkers Market: Sales Value (in Million US$), 2018 & 2023
- Figure 37: North America: Neurological Biomarkers Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 38: United States: Neurological Biomarkers Market: Sales Value (in Million US$), 2018 & 2023
- Figure 39: United States: Neurological Biomarkers Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 40: Canada: Neurological Biomarkers Market: Sales Value (in Million US$), 2018 & 2023
- Figure 41: Canada: Neurological Biomarkers Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 42: Asia-Pacific: Neurological Biomarkers Market: Sales Value (in Million US$), 2018 & 2023
- Figure 43: Asia-Pacific: Neurological Biomarkers Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 44: China: Neurological Biomarkers Market: Sales Value (in Million US$), 2018 & 2023
- Figure 45: China: Neurological Biomarkers Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 46: Japan: Neurological Biomarkers Market: Sales Value (in Million US$), 2018 & 2023
- Figure 47: Japan: Neurological Biomarkers Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 48: India: Neurological Biomarkers Market: Sales Value (in Million US$), 2018 & 2023
- Figure 49: India: Neurological Biomarkers Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 50: South Korea: Neurological Biomarkers Market: Sales Value (in Million US$), 2018 & 2023
- Figure 51: South Korea: Neurological Biomarkers Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 52: Australia: Neurological Biomarkers Market: Sales Value (in Million US$), 2018 & 2023
- Figure 53: Australia: Neurological Biomarkers Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 54: Indonesia: Neurological Biomarkers Market: Sales Value (in Million US$), 2018 & 2023
- Figure 55: Indonesia: Neurological Biomarkers Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 56: Others: Neurological Biomarkers Market: Sales Value (in Million US$), 2018 & 2023
- Figure 57: Others: Neurological Biomarkers Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 58: Europe: Neurological Biomarkers Market: Sales Value (in Million US$), 2018 & 2023
- Figure 59: Europe: Neurological Biomarkers Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 60: Germany: Neurological Biomarkers Market: Sales Value (in Million US$), 2018 & 2023
- Figure 61: Germany: Neurological Biomarkers Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 62: France: Neurological Biomarkers Market: Sales Value (in Million US$), 2018 & 2023
- Figure 63: France: Neurological Biomarkers Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 64: United Kingdom: Neurological Biomarkers Market: Sales Value (in Million US$), 2018 & 2023
- Figure 65: United Kingdom: Neurological Biomarkers Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 66: Italy: Neurological Biomarkers Market: Sales Value (in Million US$), 2018 & 2023
- Figure 67: Italy: Neurological Biomarkers Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 68: Spain: Neurological Biomarkers Market: Sales Value (in Million US$), 2018 & 2023
- Figure 69: Spain: Neurological Biomarkers Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 70: Russia: Neurological Biomarkers Market: Sales Value (in Million US$), 2018 & 2023
- Figure 71: Russia: Neurological Biomarkers Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 72: Others: Neurological Biomarkers Market: Sales Value (in Million US$), 2018 & 2023
- Figure 73: Others: Neurological Biomarkers Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 74: Latin America: Neurological Biomarkers Market: Sales Value (in Million US$), 2018 & 2023
- Figure 75: Latin America: Neurological Biomarkers Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 76: Brazil: Neurological Biomarkers Market: Sales Value (in Million US$), 2018 & 2023
- Figure 77: Brazil: Neurological Biomarkers Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 78: Mexico: Neurological Biomarkers Market: Sales Value (in Million US$), 2018 & 2023
- Figure 79: Mexico: Neurological Biomarkers Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 80: Others: Neurological Biomarkers Market: Sales Value (in Million US$), 2018 & 2023
- Figure 81: Others: Neurological Biomarkers Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 82: Middle East and Africa: Neurological Biomarkers Market: Sales Value (in Million US$), 2018 & 2023
- Figure 83: Middle East and Africa: Neurological Biomarkers Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 84: Middle East and Africa: Neurological Biomarkers Market: Breakup by Country (in %), 2023
- Figure 85: Global: Neurological Biomarkers Industry: SWOT Analysis
- Figure 86: Global: Neurological Biomarkers Industry: Value Chain Analysis
- Figure 87: Global: Neurological Biomarkers Industry: Porter's Five Forces Analysis
List of Tables
- Table 1: Global: Neurological Biomarkers Market: Key Industry Highlights, 2023 and 2032
- Table 2: Global: Neurological Biomarkers Market Forecast: Breakup by Type (in Million US$), 2024-2032
- Table 3: Global: Neurological Biomarkers Market Forecast: Breakup by Application (in Million US$), 2024-2032
- Table 4: Global: Neurological Biomarkers Market Forecast: Breakup by End Use (in Million US$), 2024-2032
- Table 5: Global: Neurological Biomarkers Market Forecast: Breakup by Region (in Million US$), 2024-2032
- Table 6: Global: Neurological Biomarkers Market: Competitive Structure
- Table 7: Global: Neurological Biomarkers Market: Key Players
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.